This study is looking at whether a dietary supplement called Myo-inositol can help prevent gestational diabetes (diabetes that develops during pregnancy). Myo-inositol is a natural compound that can improve how your body uses insulin. You might be able to join if you are pregnant with one baby, are between 18 and 45 years old, are obese (pre-pregnancy BMI of 30 or higher), and are less than 16 weeks pregnant. You also need to be receiving prenatal care and planning to give birth at Tufts Medical Center. The study will measure your glucose (sugar) levels to see if Myo-inositol is effective. The study is currently recruiting about 40 participants.

Study design

This is a double-blind randomized controlled trial, meaning neither you nor your doctor will know if you are receiving Myo-inositol or a placebo (an inactive substance). The study plans to enroll 40 participants.

What's involved

You would begin taking either Myo-inositol or a placebo upon joining the study. You must be able to tolerate a glucose tolerance test and be willing to wear a continuous glucose monitor (CGM).

Compensation

Not stated in the trial record.

Follow-up

Your eligibility and glucose levels will be measured at 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.